ZO Skin Health, Inc., a leading name in the dermatological industry, is headquartered in the United States and operates extensively across North America and beyond. Founded in 2007 by renowned dermatologist Dr. Zein Obagi, the company has established itself as a pioneer in skin health solutions, focusing on innovative skincare products and professional treatments. Specialising in advanced skincare formulations, ZO Skin Health offers a comprehensive range of products designed to address various skin concerns, from anti-ageing to pigmentation issues. Their unique approach combines medical-grade ingredients with a commitment to education, empowering both professionals and consumers to achieve optimal skin health. With a strong market position, ZO Skin Health is recognised for its scientific rigor and efficacy, making it a trusted choice among dermatologists and skincare professionals worldwide. The brand's dedication to research and development continues to set it apart in the competitive skincare landscape.
How does ZO Skin Health, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
ZO Skin Health, Inc.'s score of 31 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ZO Skin Health, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Blackstone Inc., which may influence its climate commitments and emissions reporting. As of now, ZO Skin Health, Inc. has not established any documented reduction targets or initiatives related to the Science Based Targets initiative (SBTi). Additionally, there are no climate pledges or specific reduction initiatives reported. The absence of emissions data and reduction targets suggests that ZO Skin Health, Inc. may still be in the early stages of developing a comprehensive climate strategy. As part of the broader corporate family under Blackstone Inc., it is essential for ZO Skin Health to align with industry standards and best practices in climate action to enhance its sustainability profile.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 274,000 | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 | 
| Scope 2 | 7,883,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 
| Scope 3 | 16,632,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 
ZO Skin Health, Inc.'s Scope 3 emissions, which increased by 6% last year and increased by approximately 19% since 2019, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 60% of total emissions under the GHG Protocol, with "Business Travel" being the largest emissions source at 66% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
ZO Skin Health, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.